COMPARISON OF ANTI-XA LEVELS BETWEEN OBESE AND NON-OBESE CRITICALLY ILL PATIENTS RECEIVING UNFRACTIONATED HEPARIN THROMBOPROPHYLAXIS

被引:0
|
作者
Blum, Mark [1 ]
Park, Jayoung [2 ]
Wu, Wenchen [2 ]
Belchikov, Yuly [1 ]
Smith, Candace [2 ]
Barrera, Rafael [1 ]
机构
[1] Long Isl Jewish Med Ctr, Queens, NY 11004 USA
[2] St Johns Univ, Collegeville, MN 56321 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
933
引用
收藏
页码:U254 / U254
页数:1
相关论文
共 50 条
  • [1] THROMBOPROPHYLAXIS USING ANTI-XA LEVELS IN OBESE CRITICALLY ILL PATIENTS: A RETROSPECTIVE STUDY
    Cagliani, Joaquin
    Nio, Kosuma
    Wu, Wenchen
    Smith, Candace
    Park, Jayoung
    Rik, Horacio
    Nicastro, Jeffrey
    Barrera, Rafael
    [J]. CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [2] Comparison of Anti-Xa Levels in Obese and Non-Obese Pediatric Patients Receiving Treatment Doses of Enoxaparin
    Richard, Ashley A.
    Kim, Shelly
    Moffett, Brady S.
    Bomgaars, Lisa
    Mahoney, Donald, Jr.
    Yee, Donald L.
    [J]. JOURNAL OF PEDIATRICS, 2013, 162 (02): : 293 - 296
  • [3] Anti-Xa levels in critically ill patients receiving dalteparin for thromboprophylaxis.
    McDonald, E
    Dale, C
    Pleasance, S
    McNeill, A
    Harvey, J
    Wynne, C
    Duffett, M
    Provost, L
    Rioux, A
    LaRouche, G
    Davidson, C
    Watpool, I
    McCardle, T
    Foxall, J
    Bouwers, K
    Lewis, MJ
    Zytaruk, N
    Griffith, L
    Crowther, M
    Cook, D
    [J]. BLOOD, 2004, 104 (11) : 105B - 105B
  • [4] Intravenous unfractionated heparin dosing in obese patients using anti-Xa levels
    Alex M. Ebied
    Tammy Li
    Samantha F. Axelrod
    Douglas J. Tam
    Yiqing Chen
    [J]. Journal of Thrombosis and Thrombolysis, 2020, 49 : 206 - 213
  • [5] Intravenous unfractionated heparin dosing in obese patients using anti-Xa levels
    Ebied, Alex M.
    Li, Tammy
    Axelrod, Samantha F.
    Tam, Douglas J.
    Chen, Yiqing
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (02) : 206 - 213
  • [6] Anti-Xa activity by weight in critically ill patients receiving unfractionated heparin for venous thromboembolism prophylaxis
    Aggarwal, Meera, V
    Jarrell, Andrew S.
    Gilmore, Vi T.
    Aboagye, Jonathan K.
    Haut, Elliott R.
    Hobson, Deborah B.
    Lau, Brandyn D.
    Kickler, Thomas
    Kraus, Peggy S.
    Shaffer, Dauryne L.
    Shermock, Kenneth M.
    Streiff, Michael B.
    Zheng, Gang
    Kruer, Rachel M.
    [J]. JOURNAL OF CRITICAL CARE, 2019, 52 : 180 - 185
  • [7] Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin
    Gibson, JL
    Ekevall, K
    Walker, I
    Greer, IA
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (07): : 795 - 797
  • [8] Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin
    Laifer, SA
    Casele, HL
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (06): : 614 - 615
  • [9] Agreement between activated partial thromboplastin time and anti-Xa activity in critically ill patients receiving therapeutic unfractionated heparin
    Ratano, Damian
    Alberio, Lorenzo
    Delodder, Frederik
    Faouzi, Mohamed
    Berger, Mette M.
    [J]. THROMBOSIS RESEARCH, 2019, 175 : 53 - 58
  • [10] Factors Influencing anti-Xa assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin
    Lasne, Dominique
    Toussaint-Hacquard, Marie
    Delassasseigne, Celine
    Bauters, Anne
    Flaujac, Claire
    Savard, Philippe
    Mouton, Christine
    De Maistre, Emmanuel
    Stepanian, Alain
    Eschwege, Valerie
    Delrue, Maxime
    Georges, Jean-Louis
    Gros, Antoine
    Mansour, Alexandre
    Leroy, Guillaume
    Jouffroy, Romain
    Mattei, Matthieu
    Beurton, Antoine
    Pontis, Adeline
    Neuwirth, Marie
    Nedelec-Gac, Fabienne
    Lecompte, Thomas
    Curis, Emmanuel
    Siguret, Virginie
    Gouin-Thibault, Isabelle
    [J]. THROMBOSIS AND HAEMOSTASIS, 2023, 123 (12) : 1105 - 1115